11.1. Rationale for follow-up after urethral surgery
The rationale for following-up patients after urethral stricture surgery is to detect and manage any complication or recurrence. As with any surgical procedure, following urethroplasty some patients will present with complications at short to medium follow-up: up to 34-38% of all anterior urethroplasties. Most of these complications (92-99.1%) would be classified as Clavien grade 1 or 2 [558,559]. Even though urethroplasty techniques provide the highest chances for successful treatment of urethral strictures, some patients will experience recurrence . For further details on particular outcomes in each urethral segment, please review the individual chapters of this Guideline.
Summary of evidence
After urethroplasty surgery, recurrent strictures appear with different frequency depending on stricture features and urethroplasty techniques.
Offer follow-up to all patients after urethroplasty surgery.
11.2. Definition of success after urethroplasty surgery
The “traditional academic” definition of post-operative success after urethroplasty has been considered as “The lack of any post-operative intervention for restricture” . This definition, despite being widely used [305,558] is problematic as it ignores asymptomatic or even symptomatic recurrences in patients not willing to undergo further surgeries . There is some variation as to what is considered intervention with some groups accepting endoscopic treatments as success, while considering failure only as the requirement for a ReDo urethroplasty .
A more objective definition of success is the “anatomic success”, defined as “Normal urethral lumen during RUG or cystoscopy, regardless of patient symptoms”. Using this definition, stricture recurrence or anatomical failure is considered by some groups as urethral narrowing found to be endoscopically impassable – without force – with a 16 Fr flexible endoscope [145,561]. This definition is certainly stricter, with up to 35% of cystoscopic recurrences after bulbar urethroplasty remaining asymptomatic, and thus would have been considered as successful if a “lack of further intervention” definition was used . Other groups consider cystoscopic recurrence as any stricture that is visible on post-operative cystoscopy, even the so-called “large calibre re-strictures” (> 17 Fr) . Not all anatomic recurrent strictures would need further treatment . It was suggested to intervene when the anatomic recurrence is associated with recurrence of symptoms, stricture-related high post-void residuals or a stricture calibre of < 14 Fr – even if these are asymptomatic .
Over the last ten years, the evaluation of urethral surgery outcomes has shifted towards a “patient-reported definition of success”. The aim of any urethral intervention is to allow patients to return to a normal state of voiding while maintaining QoL or to minimise symptoms, reduce disability, and improve HRQoL by restoring normal urinary function . Even if the surgeon reconstructed a wide and patent urethra, if patients experience pain, sexual dysfunction or perceive their urinary function as not improved, they will not rate their outcome as successful . On a multivariate analysis including both patient-reported and clinical parameters, urine flowmetry parameters failed to demonstrate significant contribution to satisfaction . Kessler et al., reported that only 78.3% of patients with clinical success described themselves as (very) satisfied. More dissatisfaction significantly appeared with penile curvature, penile shortening, worsening of erectile function and impairment of sexual life . Conversely, 80% of patients defined as clinical failures considered themselves as (very) satisfied with their outcomes . Regardless of anatomic success after urethroplasty, post-operative pain, sexual dysfunction and persistent LUTS were independent predictors of patient dissatisfaction . Improvement in voiding function (i.e., statistical improvement on IPSS) alone does not predict patient satisfaction after urethroplasty . On a multivariate analysis including both patient-reported and clinical parameters, after adjusting for disease recurrence and age, persistence in voiding symptoms (weak stream), genitourinary pain, and post-operative sexual function alterations were the greatest independent drivers of post-operative dissatisfaction . In addition, penile shortening (OR: 2.26; 95% CI: 1.39-3.69) and chordee (OR: 2.26; 95% CI: 1.44-4.19) were independent predictors of patient dissatisfaction after urethroplasty  (Table 11.1).
Table 11.1: Predictors of patient dissatisfaction after urethral surgery
Measure of effect
Weak/very weak urinary stream
Kessler TM et al.
J Urol 2002 
Worsening of erectile function
Impairment of sexual life
Sexual activity alteration
OR: 4.36 (1.54 – 12.37)*
Bertrand LA et al.
J Urol 2016 
Erection confidence (SHIM)
OR: 1.53 (1.12 – 2.07)*
Inability to ejaculate (MSHQ)
OR: 1.52 (1.15 – 2.01)*
OR: 1.71 (1.05 - 2.77)*
OR: 2.74 (1.12 – 6.69)*
Urinary strain (CLSS)
OR: 3.23 (1.74 – 6.01)*
OR: 2.01 (1.29 – 3.13)*
Voiding quality of life (IPSS)
OR: 1.96 (1.42 – 2.72)*
OR: 2.26 (1.39-3.69)**
Maciejewski CC et al.
Urology 2017 
OR: 2.26 (1.44 – 4.19)**
SHIM = Sexual Heath Inventory for Men; MSHQ = Male Sexual Health Questionnaire;CLSS = Core Lower Urinary Tract Symptom Score; IPSS = International Prostate Symptoms Score.
Due to this evident discrepancy between surgeon’s assessment and patient assessment, PROMs have been developed for the follow-up after urethroplasty [160,562].
A complete approach for urethral surgery outcomes would combine both anatomic, endoscopic, and Patient-reported success [560,566]. The Panel suggest using a functional definition of success in clinical practice, namely “lack of symptoms and/or need for further interventions”.
Collecting standardised documentation of the patient’s subjective assessment of their symptoms and objective anatomic outcomes would be limited for academic purposes, in order to allow comparison of surgical outcomes among reconstructive urologic surgeons and centres. Those objective and subjective outcomes measures should therefore be assessed and reported (simultaneously but separately) when evaluating urethroplasty results .
11.3. Follow-up tools after urethral surgery
11.3.1. Diagnostic tools for follow-up after urethral surgery
126.96.36.199. Calibration during follow-up after urethral surgery
The difference between calibration and urethral dilatation is usually subjective as soft strictures may be dilated during calibration ; therefore, urethral calibration should be used with caution for follow-up after urethroplasty. Dedicated calibration bougies should be used and not dilatators.
188.8.131.52. Urethrocystoscopy during follow-up after urethral surgery
Urethrocystoscopy has been considered the most useful tool to confirm the presence or absence of a recurrent stricture [143,568], as up to 35% of patients with re-strictures remain asymptomatic . Also, the cystoscope could be a measure to calibrate the strictured lumen, bearing in mind the most commonly used endoscopes: 15.7 Fr (5 mm diameter) or 17.3 Fr (5.5 mm diameter) . Urethrocystoscopy allows differentiation of recurrences as diaphragm/cross-bridging – responding to simple intervention, or significant urethral restrictures – requiring repeated interventions or ReDo surgeries . Endoscopic assessment at three months after anterior urethroplasty can predict the risk for further re-intervention at one year. Compared to normal endoscopy, large calibre (> 17 Fr) restrictures have a HR of 3.1 (1.35-7.29) for repeat intervention while small calibre (< 17 Fr) restrictures have a 23.7 HR (12.44-45.15) adjusted for age, stricture length, location, and aetiology . The main problem with using urethrocystoscopy for routine follow-up is the low compliance of patients as only 54% of patients underwent endoscopy at one year after urethroplasty, even when it was a part of a study protocol .
184.108.40.206. Retrograde urethrogram and voiding cystourethrogram during follow-up after urethral surgery
Retrograde urethrogram combined with VCUG are commonly used to confirm suspected recurrence [570,571] or as part of a routine protocol to assess post-operative urethral patency [572,573].
220.127.116.11. Urethral ultrasound – Sonourethrography during follow-up after urethral surgery
The use of SUG as a follow-up tool is not very common. It would be a reliable tool for diagnostic recurrent strictures .
11.3.2. Screening tools for follow-up after urethral surgery
These tools are used to assess whether there is suspicion of stricture recurrence and need for subsequent diagnostic evaluation (see section 5. Diagnostic evaluation).
18.104.22.168. Flow-rate analysis during follow-up after urethral surgery
Evaluating the Qmax is the commonest follow-up tool. Different cut-off points from Qmax 15 ml/s or 12 ml/s were suggested to consider the intervention as a failure or to trigger a confirmatory test for recurrence . There is no clear threshold, and 19% of patients with Qmax < 14 ml/s would still have a patent urethra, allowing passage of 15 Fr cystoscope .
Flow rates may be affected by operator error, BPO/LUTS, bladder dysfunction, and variations in bladder capacity. Further limitations of uroflowmetry include the need for a minimum voided volume of 125-150 ml to reach a voided flow rate that reliably predicts an abnormality . Even in controlled settings, the percentage of patients with adequate pre- and post-operative uroflowmetry analysis is only 31% . Comparing both pre- and post-operative Qmax levels was suggested, and a difference in Qmax of 10 ml/s or less is found to be a reliable screen tool for recurrence (sensitivity 92%, specificity 78%). This measure also has strong reproducibility (R=0.52) . Unfortunately, this improvement after urethroplasty is significantly different between age groups, with less than 10 ml/s average change in those over 65 years old, probably affected by BPO and/or bladder dysfunction . Another parameter to consider is the shape of the voiding curve, recording it as flat (obstructed) or bell-shaped . An obstructive voiding curve demonstrated 93% sensitivity to predict recurrent strictures, while a combination of urinary symptoms and obstructive voiding curve achieved 99% sensitivity and 99% NPV .
22.214.171.124. Post-void residual ultrasound measure during follow-up after urethral surgery
Post-void residual US measure is significantly increased in patients with recurrent strictures compared with those without recurrences . Unfortunately, PVR measurement is affected by abdominal ascites, bladder diverticula and/or poor bladder function , with some studies reporting inconsistent correlation with obstruction in the presence of BPO. Also, US measures of PVR are user dependent, showing high interobserver variability. Combined with other tests – uroflowmetry, IPSS, and SUG – PVR achieves adequate predictive values , but currently there is no literature to support its solo use, to assess urethral stricture recurrence .
126.96.36.199. Symptom questionnaires during follow-up after urethral surgery
The IPSS questionnaire, despite being designed for BPO, showed significant improvement after successful urethroplasty and inverse significant correlation with Qmax [565,567]. The mean improvement of IPSS is
around -11 points (range -19 to -5) .
Table 11.2: Post-urethroplasty changes in IPSS values
Mean pre-operative value
Mean post-operative value
Morey AF et al.
p < 0.0001
DeLong J et al.
-11 (IQR -19 - -5)
p < 0.001
Maciejewski CC et al. 2017 
18.7 (+/- 9)
5.8 (+/- 5)
p < 0.0001
N = number of patients; NR = not reported; IPSS = International Prostate Symptoms Score;IQR = interquartile range.
Combination of IPSS and Qmax analysis was suggested to diagnose recurrences. Using an IPSS cut-off point of 10 points associated with Qmax > 15 ml/s would prevent further invasive studies in 34% of patients, while only 4.3% of strictures < 14 Fr would have been missed. Using an IPSS cut-off point of 15 points associated with Qmax > 15 ml/s would prevent further invasive studies in 37% of cases, while 6% of strictures < 14 Fr would have been missed .
The Visual Prostate Symptom Score (VPSS) was also used to diagnose recurrent urethral strictures, offering a significantly shorter time to completion compared with IPSS, especially in cases of illiteracy or limited education. Visual Prostate Symptom Score showed a good correlation with IPSS, Qmax and urethral diameter. A combination of VPSS > 8 with Qmax < 15 ml/s had a NPV of 89% and a PPV of 87% for recurrent urethral strictures .
Post-micturition dribble, assessed by the specific question of the USS-PROM questionnaire, was present in 73% of patients pre-operatively and 40% after anterior urethroplasty, while only 6.3% was de novo. Incidence was not predicted by stricture location nor urethroplasty type .
11.3.3. Quality of life assessment, including disease specific questionnaires during follow-up after urethral surgery
Urethral stricture affects QoL evaluated by EQ-5D-3L questionnaire. Pre-operative anxiety and depression was found in 29% of patients. De novo AD after urethroplasty is uncommon (10%) and has two predictors: decreased sexual function and poor reported image of overall health . A more recommended approach is the assessment of the condition-related QoL . The USS-PROM proved useful to assess outcomes in anterior urethroplasty patients . Its use also received criticism, as some of the individual generic QoL questions do not improve after successful urethroplasty, as they are not condition-specific . Currently, there is another version of PROM, being developed and validated by a North American collaborative group, including questions related to the sexual consequences of urethral stricture disease . PROM questionnaires should be implemented in each visit to check for functional success, as they are able to show improvement over time.
The Core Lower Urinary Tract Symptom Score (CLSS) questionnaire was used to assess pre- and post-urethroplasty pain in the bladder, penis/urethra, and perineum/scrotum. Most of the parameters improved after urethroplasty, but up to 29% of patients reported worsening of perineal pain after surgery .
Sexual function should be evaluated by validated tools if not assessed in a PROM. The international index on erectile function (IIEF), SHIM, O´Leary Brief Male Sexual Function Inventory (BMFSI), SLQQ (Sexual Life Quality Questionnaire), Male Sexual Health Questionnaire (MSHQ) have all been used after urethroplasties for evaluation of erectile and ejaculatory functions. Other non-validated tools were suggested such as the Post- Urethroplasty Sexual Questionnaire (PUSQ)  or specific questionnaires for genital appearance (length, curvature) or sensitivity .
Summary of evidence
Retrograde urethrography and urethrocystoscopy are able to identify anatomical success after a urethroplasty.
A significant gap was demonstrated between objective and subjective outcomes after urethroplasties. PROM questionnaires are specific tools to assess subjective outcomes and patient satisfaction after urethroplasty surgeries.
Validated questionnaires proved useful to assess the consequences of urethral surgery on sexual function.
Use cystoscopy or retrograde urethrography to assess anatomic success after urethroplasty surgery.
Use PROM questionnaires to assess subjective outcomes and patient satisfaction.
Use validated questionnaires to evaluate sexual function after urethral stricture surgeries.
11.4. Ideal follow-up interval after urethral surgery
The optimal follow-up strategy must allow for an objective determination of anatomic and functional outcomes to assess surgical success whilst avoiding excessive invasive testing that leads to unnecessary cost, discomfort, anxiety, and risk .
After anterior urethroplasty, 21% of recurrences are clinically evident, and cystoscopically confirmed, after three months  and 96% after one year . Early recurrences are more frequent in patients with LS and older age, in longer strictures and when skin grafts were used .
11.5. Length of follow-up after urethral surgery
The median time of recurrence after bulbar urethroplasty is approximately ten months . In case series, between 55.4%  and 96% [569,572] of all recurrences are detected during the first year of follow-up after urethral surgery. Twenty-three percent of bulbar stricture recurrences are detected during the second year of follow-up, and the percentage of recurrences decreases after the second year .
On the other hand, long-term follow-up studies highlighted the role of length of follow-up as a predictor for stricture recurrence after bulbar urethroplasty [346,588]. Late recurrences – later than five years after urethroplasty – could be observed in up to 15% of cases [144,331,346]. This should be considered mainly after augmentation urethroplasties, especially in case skin grafts were used . Certainly, patients should be instructed to seek urological evaluation if they experience late recurrent symptoms .
11.6. Risk-stratified proposals during follow-up after urethral surgery
Cost of follow-up after urethroplasty is higher in the first year after the procedure . In a literature review it ranged between 205 to 1,784 US Dollars, with higher costs associated to posterior urethral repairs . As the risk of recurrence and side effects are related to the type of stricture and urethroplasty, a different follow-up schedule was proposed and shown to be cost-effective in the USA, potentially saving up to 85% of costs after five years :
- Urethroplasties with a low risk of recurrence (EPA urethroplasty without history of radiotherapy, hypospadias, or LS features) could be safely followed up based on monitoring of symptoms, using selfadministered IPSS questionnaire, every three months for one year, and annually thereafter.
- Urethroplasties with standard risk of recurrence (urethroplasty using grafts, flaps, and/or post-irradiation, hypospadias and/or LS patients) could combine IPSS questionnaire + flowmetry every three months for one year, and annually thereafter. Additionally, RUG at three and twelve months should be performed.
In this protocol, urethrocystoscopy is only performed if required . Another suggested follow-up protocol includes urethrocystoscopy or RUG/VCUG at three months post-operatively, in order to rule out early failures, especially in case of graft use. If there is evidence of good anatomical outcome in these tests, flowmetry and questionnaire results at three months should be considered as the new baseline. Thereafter, follow-up could be safely and routinely performed with non-invasive tests (flowmetry – evaluating Qmax and the shape of curve – and questionnaires). Any deterioration should be further investigated with a urethrocystoscopy .
A recently suggested protocol also included assessment of LUTS, sexual function (erectile and ejaculatory), and LUT pain, that need to be compared with pre-operative findings which should include a PROM questionnaire . Cystoscopy and flowmetry should be performed between three to six months postoperatively, and flowmetry findings should be considered as the new baseline for longitudinal follow-up. Future significant decline (25-30%) in Qmax or Qmax - (average flow rate) should trigger new cystoscopy to rule out anatomic recurrence, even in patients who are symptom-free . A routine cystoscopy at twelve to fifteen months should be performed at the surgeon’s discretion, based on risk assessment of three aspects: higher-risk patients, evidence of partial urethral narrowing at three-month assessment, low-volume surgeons .
Summary of evidence
The higher percentage of recurrences presents during the first twelve months, after urethroplasty surgery.
Risk-adjusted follow-up protocols are cost-effective and safe for the patients.
Offer a routine follow-up of at least one year after urethroplasty.
Adopt a risk-adjusted follow-up protocol.
11.7. Follow-up protocol proposal after urethroplasty
11.7.1. Surgeries with low risk of recurrence
- Anastomotic urethroplasties in the bulbar/(bulbo)membranous segment with no history of radiotherapy, hypospadias, or balanitis xerotica obliterans (BXO)/LS features.
Table 11.3: Follow-up protocol for urethroplasty with low risk of recurrence
PROM (incl. sexual function)
Anatomic evaluation: (Urethrocystoscopy/ RUG-VCUG)
*Follow-up could be discontinued after two years, advising the patient to seek urological evaluation ifsymptoms worsen. Academic centres could increase the length of follow-up for research purposes.**The Panel suggests performing an anatomic assessment at three months.
11.7.2. Surgical management options with standard risk of recurrence
- Anastomotic urethroplasties in the bulbar segment with prior history of radiotherapy, hypospadias, or BXO/LS features;
- Penile urethroplasties;
- Non-traumatic posterior urethroplasties;
- Graft or/and flap – substitution – urethroplasties.
Table 11.4: Follow-up protocol for urethroplasty with standard risk of recurrence
5 years *
PROM (incl. sexual function)
Anatomic evaluation: (Urethrocystoscopy/ RUG-VCUG)
* Follow-up could be discontinued after five years, advising the patient to seek urological evaluation ifsymptoms worsen. A longer follow-up period should be considered after penile and substitution urethroplasties.Academic centres could increase the length of follow-up for research purposes.
Please see Figure 11.1 for further guidance.
Figure 11.1: Follow-up after urethroplasty
BXO = balanitis xerotica obliterans; LS = lichen sclerosus; PROM = patient reported outcome measure;Qmax = maximum flow rate; RUG = retrograde urethrography; VCUG = voiding cystourethrography.